Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose fluoxetine effects on brain and motor activity after chronic stroke
2008-003349-97Phase 2Active
- Sponsor
- Roessingh Research & Development
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluoxetine in ischemic stroke and stroke, sponsored by Roessingh Research & Development. Primary endpoints: Change in cortical activity with fluoxetine during movement observation and execution and Relationship between cortical activity changes and motor function. Started Jun 2008; status: active.
02
Drugs
fluoxetine
03
Conditions
ischemic strokestroke
Beyond the preview
Go deeper on 2008-003349-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003349-97.